skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Scintigraphic characterization of amyloid cardiomyopathy

Journal Article · · Clin. Nucl. Med.; (United States)

Amyloidosis is an important entity in the differential diagnosis of cardiac failure of undetermined etiology. In this case report, the typical pattern of combined systolic and diastolic impairment in amyloid cardiomyopathy was demonstrated by analysis of the cardiac blood pool study. In addition, the patient described had mild uptake of Ga-67 citrate, as well as the characteristically intense myocardial uptake of Tc-99m pyrophosphate. Scintigraphic assessment may be particularly helpful when the diagnosis of amyloidosis is being considered in a patient with unexplained cardiac failure.

Research Organization:
Univ. of Michigan Medical Center, Ann Arbor
OSTI ID:
5200017
Journal Information:
Clin. Nucl. Med.; (United States), Vol. 3
Country of Publication:
United States
Language:
English

Similar Records

Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy
Journal Article · Sun Mar 01 00:00:00 EST 1987 · Am. Heart J.; (United States) · OSTI ID:5200017

Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis
Journal Article · Thu Apr 01 00:00:00 EST 1982 · Am. Heart J.; (United States) · OSTI ID:5200017

Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis
Journal Article · Tue Mar 01 00:00:00 EST 1983 · Am. J. Cardiol.; (United States) · OSTI ID:5200017